HRT Financial’s Stealth BioTherapeutics Corp. ADS MITO Stock Holding History

HRT Financial’s Portfolio MITO Stock Details MITO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-36,342	Closed	-$9K	–	3802
2022 Q2	$9K	Buy	+36,342	New	+$12.5K	﹤0.01%	2700
2021 Q4	–	Sell	-19,835	Closed	-$26K	–	4393
2021 Q3	$26K	Buy	19,835 +2,368	+14%	+$3.21K	﹤0.01%	3126
2021 Q2	$27K	Sell	17,467 -500	-3%	-$698	﹤0.01%	2711
2021 Q1	$28K	Buy	+17,967	New	+$30.9K	﹤0.01%	2586
2020 Q4	–	Sell	-17,092	Closed	-$23K	–	2689
2020 Q3	$23K	Buy	17,092 +3,341	+24%	+$5.72K	﹤0.01%	1769
2020 Q2	$25K	Buy	+13,751	New	+$25.1K	﹤0.01%	1393

Other funds holding MITO

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HRT Financial's MITO Position: Q3 2022 in Review

HRT Financial sold out of Stealth BioTherapeutics Corp. ADS (MITO) in Q3 2022, closing a stake of 36,342 shares — an estimated $9K sold.

HRT Financial first reported a position in MITO in Q2 2020 and held it in 6 quarters. The position peaked at $28K in Q1 2021. 12 funds tracked by Wall St. Rank hold MITO as of Q3 2022.

HRT Financial reported no remaining Stealth BioTherapeutics Corp. ADS position as of Q3 2022 after selling out during the quarter.
HRT Financial sold 36,342 Stealth BioTherapeutics Corp. ADS shares in Q3 2022, an estimated $9K.
HRT Financial first reported a position in Stealth BioTherapeutics Corp. ADS in Q2 2020 and held it in 6 quarters.
HRT Financial's Stealth BioTherapeutics Corp. ADS position peaked at $28K in Q1 2021.
12 funds tracked by Wall St. Rank held Stealth BioTherapeutics Corp. ADS as of Q3 2022.

Based on HRT Financial's 13F filing for Q3 2022, filed 14 Nov 2022.